Update on infections in composite tissue allotransplantation

Research output: Contribution to journalArticle

Abstract

Purpose of review: Several excellent recent reviews have summarized the infectious complications of all composite tissue allograft recipients previously reported. The current review will highlight key management principles derived from these reports. Recent findings: Severe Gram-negative infections may occur in the early posttransplant period, particularly Pseudomonas spp. Cytomegalovirus continues to be a major pathogen and is closely linked to allograft rejection; however, some patients have had uncomplicated cytomegalovirus (CMV) episodes. Candida has emerged as a cause of early infections, but the incidence of invasive mold infections has been low. More descriptions of infection risk in the late posttransplant period will be helpful, as more composite tissue allotransplantation recipients survive longer. Newer immunosuppressive regimens may reduce infection risks, but more information will be helpful. Summary: Recent reports have provided expanded information on infections in composite tissue allograft recipients. Centers may choose to broaden the Gram-negative prophylaxis, and to include antifungal prophylaxis directed at Candida spp. CMV prevention protocols should take into account recent reports of CMV outcomes. Future reports should contain infection outcomes in sufficient detail to allow for constructive modifications of antimicrobial management in an era of novel immunosuppression and increasing antimicrobial resistance.

Original languageEnglish (US)
Pages (from-to)659-664
Number of pages6
JournalCurrent Opinion in Organ Transplantation
Volume18
Issue number6
DOIs
StatePublished - Dec 2013

Fingerprint

Vascularized Composite Allotransplantation
Cytomegalovirus
Infection
Composite Tissue Allografts
Candida
Immunosuppressive Agents
Pseudomonas
Immunosuppression
Allografts
Fungi

Keywords

  • Composite tissue
  • Cytomegalovirus
  • Infection
  • Pseudomonas

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Update on infections in composite tissue allotransplantation. / Avery, Robin.

In: Current Opinion in Organ Transplantation, Vol. 18, No. 6, 12.2013, p. 659-664.

Research output: Contribution to journalArticle

@article{814b3632c1b84a5098171930e563fae3,
title = "Update on infections in composite tissue allotransplantation",
abstract = "Purpose of review: Several excellent recent reviews have summarized the infectious complications of all composite tissue allograft recipients previously reported. The current review will highlight key management principles derived from these reports. Recent findings: Severe Gram-negative infections may occur in the early posttransplant period, particularly Pseudomonas spp. Cytomegalovirus continues to be a major pathogen and is closely linked to allograft rejection; however, some patients have had uncomplicated cytomegalovirus (CMV) episodes. Candida has emerged as a cause of early infections, but the incidence of invasive mold infections has been low. More descriptions of infection risk in the late posttransplant period will be helpful, as more composite tissue allotransplantation recipients survive longer. Newer immunosuppressive regimens may reduce infection risks, but more information will be helpful. Summary: Recent reports have provided expanded information on infections in composite tissue allograft recipients. Centers may choose to broaden the Gram-negative prophylaxis, and to include antifungal prophylaxis directed at Candida spp. CMV prevention protocols should take into account recent reports of CMV outcomes. Future reports should contain infection outcomes in sufficient detail to allow for constructive modifications of antimicrobial management in an era of novel immunosuppression and increasing antimicrobial resistance.",
keywords = "Composite tissue, Cytomegalovirus, Infection, Pseudomonas",
author = "Robin Avery",
year = "2013",
month = "12",
doi = "10.1097/MOT.0000000000000023",
language = "English (US)",
volume = "18",
pages = "659--664",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Update on infections in composite tissue allotransplantation

AU - Avery, Robin

PY - 2013/12

Y1 - 2013/12

N2 - Purpose of review: Several excellent recent reviews have summarized the infectious complications of all composite tissue allograft recipients previously reported. The current review will highlight key management principles derived from these reports. Recent findings: Severe Gram-negative infections may occur in the early posttransplant period, particularly Pseudomonas spp. Cytomegalovirus continues to be a major pathogen and is closely linked to allograft rejection; however, some patients have had uncomplicated cytomegalovirus (CMV) episodes. Candida has emerged as a cause of early infections, but the incidence of invasive mold infections has been low. More descriptions of infection risk in the late posttransplant period will be helpful, as more composite tissue allotransplantation recipients survive longer. Newer immunosuppressive regimens may reduce infection risks, but more information will be helpful. Summary: Recent reports have provided expanded information on infections in composite tissue allograft recipients. Centers may choose to broaden the Gram-negative prophylaxis, and to include antifungal prophylaxis directed at Candida spp. CMV prevention protocols should take into account recent reports of CMV outcomes. Future reports should contain infection outcomes in sufficient detail to allow for constructive modifications of antimicrobial management in an era of novel immunosuppression and increasing antimicrobial resistance.

AB - Purpose of review: Several excellent recent reviews have summarized the infectious complications of all composite tissue allograft recipients previously reported. The current review will highlight key management principles derived from these reports. Recent findings: Severe Gram-negative infections may occur in the early posttransplant period, particularly Pseudomonas spp. Cytomegalovirus continues to be a major pathogen and is closely linked to allograft rejection; however, some patients have had uncomplicated cytomegalovirus (CMV) episodes. Candida has emerged as a cause of early infections, but the incidence of invasive mold infections has been low. More descriptions of infection risk in the late posttransplant period will be helpful, as more composite tissue allotransplantation recipients survive longer. Newer immunosuppressive regimens may reduce infection risks, but more information will be helpful. Summary: Recent reports have provided expanded information on infections in composite tissue allograft recipients. Centers may choose to broaden the Gram-negative prophylaxis, and to include antifungal prophylaxis directed at Candida spp. CMV prevention protocols should take into account recent reports of CMV outcomes. Future reports should contain infection outcomes in sufficient detail to allow for constructive modifications of antimicrobial management in an era of novel immunosuppression and increasing antimicrobial resistance.

KW - Composite tissue

KW - Cytomegalovirus

KW - Infection

KW - Pseudomonas

UR - http://www.scopus.com/inward/record.url?scp=84888302022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888302022&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000023

DO - 10.1097/MOT.0000000000000023

M3 - Article

C2 - 24220048

AN - SCOPUS:84888302022

VL - 18

SP - 659

EP - 664

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -